Literature DB >> 23314053

Antimicrobial activity of various 4- and 5-substituted 1-phenylnaphthalenes.

Cody Kelley1, Songfeng Lu, Ajit Parhi, Malvika Kaul, Daniel S Pilch, Edmond J Lavoie.   

Abstract

Bacterial cell division occurs in conjunction with the formation of a cytokinetic Z-ring structure comprised of FtsZ subunits. Agents that can disrupt Z-ring formation have the potential, through this unique mechanism, to be effective against several of the newly emerging multi-drug resistant strains of infectious bacteria. 1- and 12-Aryl substituted benzo[c]phenanthridines have been identified as antibacterial agents that could exert their activity by disruption of Z-ring formation. Substituted 4- and 5-amino-1-phenylnaphthalenes represent substructures within the pharmacophore of these benzo[c]phenanthridines. Several 4- and 5-substituted 1-phenylnaphthalenes were synthesized and evaluated for antibacterial activity against Staphylococcus aureus and Enterococcus faecalis. The impact of select compounds on the polymerization dynamics of S. aureus FtsZ was also assessed.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23314053      PMCID: PMC3949621          DOI: 10.1016/j.ejmech.2012.12.027

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  24 in total

Review 1.  The tubulin ancestor, FtsZ, draughtsman, designer and driving force for bacterial cytokinesis.

Authors:  Stephen G Addinall; Barry Holland
Journal:  J Mol Biol       Date:  2002-04-26       Impact factor: 5.469

Review 2.  Molecules of the bacterial cytoskeleton.

Authors:  Jan Löwe; Fusinita van den Ent; Linda A Amos
Journal:  Annu Rev Biophys Biomol Struct       Date:  2004

3.  Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality.

Authors:  Danielle N Margalit; Laura Romberg; Rebecca B Mets; Alan M Hebert; Timothy J Mitchison; Marc W Kirschner; Debabrata RayChaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

Review 4.  FtsZ and the division of prokaryotic cells and organelles.

Authors:  William Margolin
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

5.  Synthesis of antimicrobial natural products targeting FtsZ: (+/-)-dichamanetin and (+/-)-2' ''-hydroxy-5' '-benzylisouvarinol-B.

Authors:  Sameer Urgaonkar; Henry S La Pierre; Israel Meir; Henrik Lund; Debabrata RayChaudhuri; Jared T Shaw
Journal:  Org Lett       Date:  2005-12-08       Impact factor: 6.005

6.  FtsZ ring formation in fts mutants.

Authors:  S G Addinall; E Bi; J Lutkenhaus
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

Review 7.  Bacterial cell division and the Z ring.

Authors:  J Lutkenhaus; S G Addinall
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

8.  GTP analogue inhibits polymerization and GTPase activity of the bacterial protein FtsZ without affecting its eukaryotic homologue tubulin.

Authors:  Tilman Läppchen; Aloysius F Hartog; Victorine A Pinas; Gerrit-Jan Koomen; Tanneke den Blaauwen
Journal:  Biochemistry       Date:  2005-05-31       Impact factor: 3.162

9.  Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores.

Authors:  Pravin L Kotian; Raman Krishnan; Scott Rowland; Yahya El-Kattan; Surendra K Saini; Ramanda Upshaw; Shanta Bantia; Shane Arnold; Y Sudhakar Babu; Pooran Chand
Journal:  Bioorg Med Chem       Date:  2009-04-12       Impact factor: 3.641

10.  Dispersed mode of Staphylococcus aureus cell wall synthesis in the absence of the division machinery.

Authors:  Mariana G Pinho; Jeff Errington
Journal:  Mol Microbiol       Date:  2003-11       Impact factor: 3.501

View more
  8 in total

Review 1.  Drug discovery targeting cell division proteins, microtubules and FtsZ.

Authors:  Iwao Ojima; Kunal Kumar; Divya Awasthi; Jacob G Vineberg
Journal:  Bioorg Med Chem       Date:  2014-03-05       Impact factor: 3.641

2.  Polyhalonitrobutadienes as Versatile Building Blocks for the Biotargeted Synthesis of Substituted N-Heterocyclic Compounds.

Authors:  Viktor A Zapol'skii; Ursula Bilitewski; Sören R Kupiec; Isabell Ramming; Dieter E Kaufmann
Journal:  Molecules       Date:  2020-06-21       Impact factor: 4.411

3.  An FtsZ-targeting prodrug with oral antistaphylococcal efficacy in vivo.

Authors:  Malvika Kaul; Lilly Mark; Yongzheng Zhang; Ajit K Parhi; Edmond J Lavoie; Daniel S Pilch
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

4.  In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model.

Authors:  Alexander J Lepak; Ajit Parhi; Michaela Madison; Karen Marchillo; Jamie VanHecker; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

5.  Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.

Authors:  Ajit K Parhi; Yongzheng Zhang; Kurt W Saionz; Padmanava Pradhan; Malvika Kaul; Kalkal Trivedi; Daniel S Pilch; Edmond J LaVoie
Journal:  Bioorg Med Chem Lett       Date:  2013-06-26       Impact factor: 2.823

Review 6.  Antibiotics and bacterial resistance in the 21st century.

Authors:  Richard J Fair; Yitzhak Tor
Journal:  Perspect Medicin Chem       Date:  2014-08-28

7.  Synthesis and evaluation of novel naphthol diazenyl scaffold based Schiff bases as potential antimicrobial and cytotoxic agents against human colorectal carcinoma cell line (HT-29).

Authors:  Harmeet Kaur; Jasbir Singh; Balasubramanian Narasimhan
Journal:  BMC Chem       Date:  2019-04-02

Review 8.  Research Progress on Antibacterial Activities and Mechanisms of Natural Alkaloids: A Review.

Authors:  Yumei Yan; Xing Li; Chunhong Zhang; Lijuan Lv; Bing Gao; Minhui Li
Journal:  Antibiotics (Basel)       Date:  2021-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.